🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A first-in-human evaluation of SYN004, a monoclonal antibody that binds to ...
Status
Completed
Location
Ochsner Medical Center
Start Date
2015-05
Trial ID
NCT02391727
Treatments Being Tested
A Phase 1b/2a, Randomized, Multi-Center, Open-Label, Fixed-Sequence Study t...
Status
Completed
Location
Multiple Locations
Start Date
2015-03
Trial ID
NCT02419001
A Phase 2b Parallel-Group, Double-Blind, Placebo-Controlled, Multicenter St...
Status
Completed
Location
Synthetic Biologics Investigational Site
Start Date
2015-10
Trial ID
NCT02563106
A Phase 1b/2a, Multi-Center, Open-Label, 2-Period, Fixed-Sequence Study Eva...
Status
Completed
Location
Synthetic Biologics Investigative Site
Start Date
2015-06
Trial ID
NCT02473640
Treatments Being Tested
A Phase 1 Dose Escalation Trial of SYN125 Single Agent in the Treatment of ...
Status
Unknown
Location
University of Kansas Cancer Center, Clinical Research Center, 4350 Shawnee Mission Parkway, MS 6004
Start Date
2020-04-09
Trial ID
NCT04363242
Study Objectives: 1. To evaluate the safety and tolerability of oral SYN-0...
Status
Active Not Recruiting
Location
Washington University
Start Date
2021-02-15
Trial ID
NCT04692181
Treatments Being Tested